{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:28:24Z","timestamp":1772166504423,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endotrophin is one of the extracellular matrix proteins secreted by adipose tissue. In this study, we aimed to investigate the effects of changes in blood glucose levels on serum endotrophin levels secreted by adipose tissue and thus on diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective pilot study included 78 patients with type 2 diabete (T2D) with hemoglobin A1c level\u2009&gt;\u20099\u2009%. Lifestyle changes were recommended and appropriate medical treatment was initiated to all patients in order to reach the target HbA1c level. Data of anthropometric measurements, urinary albumin creatinine ratio (UACR), serum lipid parameters and endotrophin were collected in patients; all examinations were repeated after 3\u2009months. Analysis was performed using Paired-Samles T test and Spearman tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of patients, 23 were female (54.8\u2009%) and 19 were male (45.2\u2009%). Mean age was 55.2\u2009years, with mean diabetes age of 8.14\u2009\u00b1\u20095.35\u2009years. After 3\u2009months follow-up, HbA1c, fasting glucose, C-reactive protein(CRP), UACR and endotrophin levels were observed to clearly reduce. The variation in serum endotrophin levels examined at the start of the study and in the 3rd month was identified to have a positive correlation with the variation in HbA1c and UACR levels (r\u2009=\u20090.342, p\u2009=\u20090.02; r\u2009=\u20090.484, p\u2009=\u20090.001). Multiple linear regression analysis showed percentage variation values (\u03b4)-endotrophin levels were only independently correlated with (\u03b4)-UACR (model r\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.257, p value\u2009=\u20090.00).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endotrophin levels decreased significantly with the decrease in HbA1c.\u00a0Unexpectedly, this reduction in endotrophin levels is closely related to the decrease in UACR, regardless of blood glucose regulation. We think that studies targeting endotrophin will contribute to the diagnosis, treatment and follow-up of diabetic nephropathy in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-021-00628-5","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T05:04:30Z","timestamp":1611205470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4236-1181","authenticated-orcid":false,"given":"Sengul Aydin","family":"Yoldemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yucel","family":"Arman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Akarsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Altun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tufan","family":"Tukek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"628_CR1","unstructured":"IDF. (2017) Diabetes atlas 8th edn. https:\/\/www.idf.org\/aboutdiabetes\/what-is-diabetes\/facts-figures.html."},{"key":"628_CR2","unstructured":"World Health Organization. https:\/\/www.who.int\/dg\/speeches\/2016\/obesity-diabetes-disaster\/en\/."},{"issue":"1","key":"628_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019386","volume":"27","author":"MI Qadir","year":"2017","unstructured":"Qadir MI, Ahmed Z. lep Expression and its role in obesity and type-2 diabetes. Crit Rev Eukaryot Gene Expr. 2017;27(1):47\u201351.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"10","key":"628_CR4","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2337\/dc11-0631","volume":"34","author":"L H\u00f8jbjerre","year":"2011","unstructured":"H\u00f8jbjerre L, Sonne MP, Alibegovic AC, et al. Impact of physical inactivity on adipose tissue low-grade inflammation in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2011;34(10):2265\u201372.","journal-title":"Diabetes Care"},{"issue":"6","key":"628_CR5","first-page":"112","volume":"12","author":"J Be\u0142towski","year":"2006","unstructured":"Be\u0142towski J. Apelin and visfatin: Unique \u201cbeneficial\u201d adipokines upregulated in obesity? Med Sci Monit. 2006;12(6):112\u201319.","journal-title":"Med Sci Monit"},{"key":"628_CR6","doi-asserted-by":"publisher","first-page":"701915","DOI":"10.1155\/2014\/701915","volume":"2014","author":"S Coimbra","year":"2014","unstructured":"Coimbra S, Brand\u00e3o-Proen\u00e7a J, Santos-Silva A, et al. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: A close linkage with obesity and length of the disease. Biomed Res Int. 2014;2014:701915.","journal-title":"Biomed Res Int."},{"key":"628_CR7","doi-asserted-by":"publisher","first-page":"13105","DOI":"10.1074\/jbc.270.22.13105","volume":"270","author":"A Colombatti","year":"1995","unstructured":"Colombatti A, Mucignat MT, Bonaldo P. Secretion and matrix assembly of recombinant type VI collagen. J Biol Chem. 1995;270:13105\u201311.","journal-title":"J Biol Chem"},{"key":"628_CR8","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1038\/ncomms4485","volume":"5","author":"K Sun","year":"2014","unstructured":"Sun K, Park J, Gupta OT, et al. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun. 2014;5:3485.","journal-title":"Nat Commun"},{"key":"628_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/emmm.201202006","volume":"5","author":"J Park","year":"2013","unstructured":"Park J, Morley TS, Scherer PE. Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med. 2013;5:935\u201348.","journal-title":"EMBO Mol Med"},{"key":"628_CR10","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1172\/JCI63930","volume":"122","author":"J Park","year":"2012","unstructured":"Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest. 2012;122:4243\u201356.","journal-title":"J Clin Invest"},{"key":"628_CR11","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Standards of Medical Care in Diabetes. 2019 https:\/\/care.diabetesjournals.org\/content\/diacare\/suppl\/2018\/12\/17\/42.Supplement_1.DC1\/DC_42_S1_2019_UPDATED.pdf.","DOI":"10.2337\/dc19-Sint01"},{"issue":"1","key":"628_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00125-016-4094-1","volume":"60","author":"MA Karsdal","year":"2017","unstructured":"Karsdal MA, Henriksen K, Genovese F, et al. Serum endotrophin identifies optimal responders to PPAR\u03b3 agonists in type 2 diabetes. Diabetologia. 2017;60(1):50\u20139. (Epub 2016 Sep 8).","journal-title":"Diabetologia."},{"issue":"1","key":"628_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00125-016-4130-1","volume":"60","author":"K Sun","year":"2017","unstructured":"Sun K, Park J, Kim M, et al. Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPAR\u03b3 agonist treatment. Diabetologia Jan. 2017;60(1):24\u20139 (Epub 2016 Oct 7).","journal-title":"Diabetologia Jan"},{"key":"628_CR14","doi-asserted-by":"publisher","first-page":"e0144525","DOI":"10.1371\/journal.pone.0144525","volume":"10","author":"S Sun","year":"2015","unstructured":"Sun S, Henriksen K, Karsdal MA, et al. Collagen type III and VI turnover in response to long-term immobilization. PLoS ONE. 2015;10:e0144525.","journal-title":"PLoS ONE"},{"issue":"4","key":"628_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","volume":"51","author":"CD Stehouwer","year":"2002","unstructured":"Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associ- ated with risk of death. Diabetes. 2002;51(4):1157\u201365.","journal-title":"Diabetes"},{"key":"628_CR16","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.1152\/ajpendo.00202.2005","volume":"290","author":"R Berria","year":"2006","unstructured":"Berria R, Wang L, Richardson D, et al. Increased collagen content in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab. 2006;290:E560-5. https:\/\/doi.org\/10.1152\/ajpendo.00202.2005 00202.2005.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"628_CR17","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1242\/dmm.032946","volume":"142","author":"P Muona","year":"1993","unstructured":"Muona P, Jaakkola S, Zhang R, et al. Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus. Am J Pathol. 1993;142:1586\u201397. doi:https:\/\/doi.org\/10.1242\/dmm.032946.","journal-title":"Am J Pathol"},{"key":"628_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nmd.2016.06.370","volume":"26","author":"M Rodriguez","year":"2016","unstructured":"Rodriguez M, Osorio-Conles O, Montori-Grau M, et al. Collagen VI and endotrophin regulate glucose homeostasis in skeletal muscle. Neuromuscul Disord. 2016;26:188. doi:https:\/\/doi.org\/10.1016\/j.nmd.2016.06.370.","journal-title":"Neuromuscul Disord"},{"key":"628_CR19","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1210\/jc.2009-0947","volume":"94","author":"M Pasarica","year":"2009","unstructured":"Pasarica M, Gowronska-Kozak B, Burk Demedios I, et al. Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab. 2009;94:5155\u201362. doi:https:\/\/doi.org\/10.1210\/jc.2009-0947.","journal-title":"J Clin Endocrinol Metab"},{"key":"628_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/0006-291X(89)92829-5","volume":"158","author":"Y Totsuka","year":"1989","unstructured":"Totsuka Y, Tabuchi M, Kojima I, et al. Stimulation of insulin secretion by transforming growth factor-beta. Biochem Biophys Res Commun. 1989;158:1060\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"628_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4172\/2157-7099.1000282","volume":"5","author":"S Fischbach","year":"2014","unstructured":"Fischbach S, Gittes GK. The Role of TGF-\u00df Signaling in \u00df-Cell Dysfunction and Type 2 Diabetes: A Review. J Cytol Histol. 2014;5:282. doi:https:\/\/doi.org\/10.4172\/2157-7099.1000282.","journal-title":"J Cytol Histol"},{"key":"628_CR22","doi-asserted-by":"publisher","first-page":"18\u2009J","DOI":"10.1016\/S0002-9149(03)00612-X","volume":"92","author":"SM Haffner","year":"2003","unstructured":"Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol. 2003;92:18\u2009J\u201326\u2009J.","journal-title":"Am J Cardiol"},{"key":"628_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","volume":"102","author":"A Festa","year":"2000","unstructured":"Festa A, D\u2019Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42\u20137.","journal-title":"Circulation"},{"key":"628_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/01.ATV0000065636.15310.9C","volume":"23","author":"AD Pradhan","year":"2003","unstructured":"Pradhan AD, Cook NR, Buring JE, et al. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003;23:650\u20135. doi:https:\/\/doi.org\/10.1161\/01.ATV0000065636.15310.9C.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"628_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2337\/db12-0133","volume":"62","author":"K Tanigaki","year":"2013","unstructured":"Tanigaki K, Vongpatanasin W, Barrera JA, et al. C-reactive protein causes insulin resistance in mice through Fcgamma receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes. 2013;62:721\u201331. doi:https:\/\/doi.org\/10.2337\/db12-0133.","journal-title":"Diabetes"},{"key":"628_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","volume":"133","author":"Y Yue","year":"2017","unstructured":"Yue Y, Meng K, Pu Y, et al. Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017;133:124\u201330. https:\/\/doi.org\/10.1016\/j.diabres.2017.08.018.","journal-title":"Diabetes Res Clin Pract."},{"key":"628_CR27","first-page":"27","volume":"112","author":"S Goldfarb","year":"2001","unstructured":"Goldfarb S, Ziyadeh FN. TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc. 2001;112:27\u201332 discussion 33.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"1","key":"628_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2337\/diacare.39.1.31","volume":"39","author":"PS Mohan","year":"1990","unstructured":"Mohan PS, Carter WG, Spiro RG. Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes. 1990;39(1):31\u20137.","journal-title":"Diabetes"},{"key":"628_CR29","doi-asserted-by":"publisher","unstructured":"Rasmussen DGK, Fenton A, Jesky M, et al. (2017) Urinary endotrophin predicts disease progression in patients with chronic kidney Dis. 11;7(1):17328. https:\/\/doi.org\/10.1038\/s41598-017-17470-3.","DOI":"10.1038\/s41598-017-17470-3"},{"issue":"4","key":"628_CR30","doi-asserted-by":"publisher","first-page":"e0175200","DOI":"10.1371\/journal.pone.0175200","volume":"12","author":"A Fenton","year":"2017","unstructured":"Fenton A, Jesky MD, Ferro CJ, et al. Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease. PLoS ONE. 2017;12(4):e0175200. https:\/\/doi.org\/10.1371\/journal.pone.0175200.","journal-title":"PLoS ONE"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13098-021-00628-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T05:26:11Z","timestamp":1611206771000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-021-00628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1186\/s13098-021-00628-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-117905\/v1","asserted-by":"object"}]},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee permission was obtained from the local ethics committee (June 2018 dated and numbered 988).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}